COVID-19: investing in country capacity to bridge science, policy and action

• Göran Tomson,
• Ludovic Reveiz,
• Marge Reinap,
• Fadi El-Jardali,
• Tanja Kuchenmüller,
• John N Lavis,
• Arash Rashidian,
• John T Grove

Affiliations

Göran Tomson

Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden

Ludovic Reveiz

Department of Evidence and Intelligence for Action in Health and Incident Management System for COVID-19, WHO Regional Office for the Americas/Pan American Health Organization, Washington, District of Columbia, USA

Marge Reinap

14 London School of Hygiene and Tropical Medicine, London, UK

Fadi El-Jardali

Department of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon

Tanja Kuchenmüller

Research for Health Department,Science Division, World Health Organization, Geneva, Switzerland

John N Lavis

McMaster Health Forum/WHO Collaborating Centre for Evidence-Informed Policy, McMaster University, Hamilton, Ontario, Canada

Arash Rashidian

executive editor

John T Grove

Department of Quality Assurance, Norms and Standards, World Health Organization, Geneve, Switzerland